The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides
Abstract
Deletions and point mutations in the gene encoding the cytoskeletal protein dystrophin and its isoforms cause either the severe progressive myopathy Duchenne muscular dystrophy (DMD) or the milder Becker muscular dystrophy (BMD), largely depending on whether the reading frame is lost or maintained respectively. Frameshift mutations tend to result in a lack of dystrophin at the sarcolemma, destabilization of the membrane and degeneration of skeletal muscle. The mdx mouse is a valuable animal model of DMD as it bears a nonsense point mutation in exon 23 of the murine DMD gene leading to an absence of dystrophin expression in the muscle sarcolemma and muscular dystrophy. This report represents a novel approach to correct dystrophin deficiency at the post-transcriptional level by transfection of muscle cells with antisense RNA. Essentially, 2'- O -methyl oligoribonucleotides (2'OMeRNA) were delivered to the nuclei of primary mdx myoblasts in culture. Dystrophin expression was observed in the sarcolemma of transfected mdx myotubes after transfection by an oligonucleotide complementary to the 3' splice site of murine dystrophin intron 22. Direct sequencing of RT-PCR products from these cells revealed precise splicing of exon 22 to exon 30, skipping the mutant exon and creating a novel in-frame dystrophin transcript. As patients with comparable in-frame internal deletions show relatively mild myopathic symptoms, this may in the future offer a therapeutic approach for DMD, as well as for other inherited disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247
Dystrophin: the protein product of the Duchenne muscular dystrophy locus
Hoffman, E. P., Brown, R. H., & Kunkel, L. M. (1987) · Cell · doi:10.1016/0092-8674(87)90579-4 · Cited by 4,693
The Molecular Basis of Muscular Dystrophy in the mdx Mouse: a Point Mutation
Sicinski, P., Geng, Y., Ryder-Cook, A. S., Barnard, E. A., Darlison, M. G., & Barnard, P. J. (1989) · Science · doi:10.1126/science.2662404 · Cited by 1,276
Monaco, A. P., Bertelson, C. J., Liechti-Gallati, S., Moser, H., & Kunkel, L. M. (1988) · Genomics · doi:10.1016/0888-7543(88)90113-9 · Cited by 1,210
Koenig, M., Beggs, A. H., Moyer, M., Scherpf, S., Heindrich, K., Bettecken, T., Meng, G., Müller, C. R., Lindlöf, M., Kääriäinen, H. A., et al. (1989) · Europe PMC (PubMed Central) · Cited by 1,113
Monia, B. P., Lesnik, E. A., Gonzalez, C., Lima, W. F., McGee, D., Guinosso, C. J., Kawasaki, A. M., Cook, P. D., & Freier, S. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85268-7 · Cited by 778
Specific regulation of gene expression by antisense, sense and antigene nucleic acids
Hélène, C., & Toulmé, J.-J. (1990) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(90)90031-v · Cited by 768
The structural and functional diversity of dystrophin
Ahn, A. H., & Kunkel, L. M. (1993) · Nature Genetics · doi:10.1038/ng0493-283 · Cited by 650
Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides.
Bennett, C. F., Chiang, M. Y., Chan, H., Shoemaker, J. E., & Mirabelli, C. K. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09229-6 · Cited by 612
Abdallah, B., Hassan, A., Benoist, C., Goula, D., Behr, J. P., & Demeneix, B. A. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.16-1947 · Cited by 541
Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides.
Dominski, Z., & Kole, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8673 · Cited by 426
The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced
Tennyson, C. N., Klamut, H. J., & Worton, R. G. (1995) · Nature Genetics · doi:10.1038/ng0295-184 · Cited by 369
Cummins, L. L., Owens, S. R., Risen, L. M., Lesnik, E. A., Freier, S. M., McGee, D., Guinosso, C. J., & Cook, P. D. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.11.2019 · Cited by 364
Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.
Beltinger, C., Saragovi, H. U., Smith, R. M., LeSauteur, L., Shah, N., DeDionisio, L., Christensen, L., Raible, A., Jarett, L., & Gewirtz, A. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117860 · Cited by 312
Selecting effective antisense reagents on combinatorial oligonucleotide arrays
Milner, N., Mir, K. U., & Southern, E. M. (1997) · Nature Biotechnology · doi:10.1038/nbt0697-537 · Cited by 261
Lewis, J. G., Lin, K. Y., Kothavale, A., Flanagan, W. M., Matteucci, M. D., DePrince, R. B., Mook, R. A., Hendren, R. W., & Wagner, R. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3176 · Cited by 256
Defects in RNA splicing and the consequence of shortened translational reading frames.
Maquat, L. E. (1996) · PubMed · Cited by 248
Repair of thalassemic human β-globin mRNA in mammalian cells by antisense oligonucleotides
Sierakowska, H., Sambade, M. J., Agrawal, S., & Kole, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.12840 · Cited by 236
Pharmacokinetic properties of several novel oligonucleotide analogs in mice.
Crooke, S. T., Graham, M. J., Zuckerman, J. E., Brooks, D., Conklin, B. S., Cummins, L. L., Greig, M. J., Guinosso, C. J., Kornbrust, D., Manoharan, M., et al. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12951-0 · Cited by 227
Self-citationVincent, N., Ragot, T., Gilgenkrantz, H., Couton, D., Chafey, P., Grégoire, A., Briand, P., Kaplan, J.-C., Kahn, A., & Perricaudet, M. (1993) · Nature Genetics · doi:10.1038/ng1093-130 · Cited by 201
Altmann, K.-H., Dean, N. M., Fabbro, D., Freier, S. M., Geiger, T., Häner, R., Hüsken, D., Martin, P., Monia, B. P., Müller, M., et al. (1996) · CHIMIA · doi:10.2533/chimia.1996.168 · Cited by 169
Chelly, J., Gilgenkrantz, H., Lambert, M., Hamard, G., Chafey, P., Récan, D., Katz, P., Chapelle, A. D. L., Koenig, M., Ginjaar, I. B., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90419-f · Cited by 162
Wells, D. J., Wells, K. E., Asante, E. A., Turner, G., Sunada, Y., Campbell, K. P., Walsh, F. S., & Dickson, G. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.8.1245 · Cited by 155
Self-citationThe Frequency of Revertants in mdx Mouse Genetic Models for Duchenne Muscular Dystrophy
Dankó, I., Chapman, V. M., & Wolff, J. A. (1992) · Pediatric Research · doi:10.1203/00006450-199207000-00025 · Cited by 144
Pramono, Z. A. D., Takeshima, Y., Alimsardjono, H., Ishii, A., Takeda, S., & Matsuo, M. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1375 · Cited by 139
Monia, B. P., Sasmor, H. M., Johnston, J. F., Freier, S. M., Lesnik, E. A., Muller, M., Geiger, T. M., Altmann, K., Moser, H. E., & Fabbro, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15481 · Cited by 136
Takeshima, Y., Nishio, H., Sakamoto, H., Nakamura, H., & Matsuo, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117693 · Cited by 130
Surface antigen differentiation during human myogenesis in culture
Walsh, F. S., & Ritter, M. A. (1981) · Nature · doi:10.1038/289060a0 · Cited by 129
Mild Congenital Muscular Dystrophy in Two Patients with an Internally Deleted Laminin 2-Chain
Allamand, V., Sunada, Y., Salih, M. A. M., Straub, V. W., Ozo, O., Al-Turaiki, M. H. S., Akbar, M., Kolo, T., Colognato, H., Zhang, X., et al. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.5.747 · Cited by 123
Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo
Dunckley, M. G., Wells, D. J., Walsh, F. S., & Dickson, G. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.6.717 · Cited by 119
Self-citationALTMANN, K. ‐., Fabbro, D., Dean, N. M., et al. (1996) · Biochemical Society Transactions · doi:10.1042/bst0240630 · Cited by 114
Exon skipping and translation in patients with frameshift deletions in the dystrophin gene.
Sherratt, T. G., Vulliamy, T., Dubowitz, V., Sewry, C. A., & Strong, P. N. (1993) · Europe PMC (PubMed Central) · Cited by 103
Thanh, L. T., Nguyen, T. M., Helliwell, T. R., et al. (1995) · PubMed · Cited by 92
Wang, S., & Kool, E. T. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.7.1157 · Cited by 76
Retroviral‐mediated transfer of a dystrophin minigene into mdx mouse myoblasts in vitro
Dunckley, M. G., Love, D. R., Davies, K. E., Walsh, F. S., Morris, G. E., & Dickson, G. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80363-l · Cited by 72
Self-citationFunctional significance of dystrophin positive fibres in Duchenne muscular dystrophy.
Nicholson, L. V. B., Johnson, M. A., Bushby, K. M. D., & Gardner‐Medwin, D. (1993) · Archives of Disease in Childhood · doi:10.1136/adc.68.5.632 · Cited by 56
Stability of the human dystrophin transcript in muscle
Tennyson, C. N. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.15.3059 · Cited by 56
Antisense oligonucleotide therapeutics: drug delivery and targeting
Rojanasakul, Y. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00020-8 · Cited by 55
Dystrophin gene transcripts skipping the mdx mutation
Wilton, S. D., Dye, D. E., & Laing, N. G. (1997) · Muscle & Nerve · Cited by 53
In vivo stability and disposition of a self-stabilized oligodeoxynucleotide phosphorothioate in rats
Zhang, R., Lu, Z., Zhang, X., Zhao, H., Diasio, R. B., Liu, T., Jiang, Z., & Agrawal, S. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.6.836 · Cited by 47
Fassati, A., Wells, D. J., Serpente, P., Walsh, F. S., Brown, S., Strong, P. N., & Dickson, G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119573 · Cited by 33
Self-citationVery small dystrophin molecule in a family with a mild form of Becker dystrophy
Morandi, L. O., Mora, M., Bernasconi, P., Mantegazza, R., Gebbia, M., Balestrini, M. R., & Cornelio, F. (1993) · Neuromuscular Disorders · doi:10.1016/0960-8966(93)90043-j · Cited by 19
Cited by
Human Splicing Finder: an online bioinformatics tool to predict splicing signals
Desmet, F.-O., Hamroun, D., Lalande, M., Collod-Béroud, G., Claustres, M., & Béroud, C. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp215 · Cited by 2,512
Antisense oligonucleotides: the next frontier for treatment of neurological disorders
Rinaldi, C., & Wood, M. J. A. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.148 · Cited by 788
Splice-switching antisense oligonucleotides as therapeutic drugs
Havens, M. A., & Hastings, M. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw533 · Cited by 538
Alternative splicing in disease and therapy
Garcia-Blanco, M. A., Baraniak, A. P., & Lasda, E. L. (2004) · Nature Biotechnology · doi:10.1038/nbt964 · Cited by 527
Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy
McGreevy, J. W., Hakim, C. H., McIntosh, M. A., & Duan, D. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.018424 · Cited by 512
Metadata
- Authors
- Dunckley, M. G., Manoharan, M., Villiet, P., Eperon, I. C., & Dickson, G.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-07-01
- Volume
- 7
- Issue
- 7
- Pages
- 1083-1090
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2100682779
- Cited by
- 255
- References
- 43
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.